AMS BioteQ
AMS BioteQ is a Taiwan-based biotechnology company (est. 2018) focused on antimicrobial research, medical-material development and natural-product drug discovery. The company develops wound dressings (foam, hydrogel, gelatin) that incorporate natural antimicrobial ingredients, pursues antiviral and anti-tumor small-molecule programs, manages an active patent portfolio, and has pursued regulatory approvals and international distribution for its medical materials.
Industries
Nr. of Employees
small (1-50)
AMS BioteQ
Products
Antimicrobial-integrated wound dressings (foam/hydrogel/gelatin formats)
Absorbent wound dressings formulated with natural antimicrobial ingredients designed to maintain moist healing, absorb exudate and promote tissue regeneration; supported by preclinical animal model data.
Natural-product antiviral drug candidates
Preclinical plant-derived small-molecule programs developed for antiviral activity and low residual toxicity; subject to in vitro and preclinical evaluation.
Antimicrobial-integrated wound dressings (foam/hydrogel/gelatin formats)
Absorbent wound dressings formulated with natural antimicrobial ingredients designed to maintain moist healing, absorb exudate and promote tissue regeneration; supported by preclinical animal model data.
Natural-product antiviral drug candidates
Preclinical plant-derived small-molecule programs developed for antiviral activity and low residual toxicity; subject to in vitro and preclinical evaluation.
Expertise Areas
- Wound care materials and dressing development
- Antimicrobial substance discovery and formulation
- Antiviral small-molecule discovery
- Oncology drug research and nanoparticle delivery
Key Technologies
- Hydrogel and foam dressing materials
- Natural product extraction and fractionation
- Composite dressing materials with controlled antimicrobial release
- Nanoparticle drug-delivery systems